The interaction of vasoactive intestinal polypeptide and secretin with liver-cell membranes.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001414:Bacitracin / Q000494:pharmacology; D001665:Binding Sites; D001667:Binding, Competitive; D002462:Cell Membrane / Q000378:metabolism; D002614:Chelating Agents / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D006150:Guanine Nucleotides / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007421:Intestine, Small; D007457:Iodine Radioisotopes; D007700:Kinetics; D008862:Microsomes, Liver / Q000378:metabolism*; D009711:Nucleotides / Q000494:pharmacology; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D009994:Osmolar Concentration; D010455:Peptides / Q000378:metabolism* / Q000494:pharmacology; D010618:Phenanthrolines / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D012633:Secretin / Q000494:pharmacology*; D013501:Surface-Active Agents / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000378:metabolism*
D002614:Chelating Agents; D006150:Guanine Nucleotides; D006728:Hormones; D007457:Iodine Radioisotopes; D009711:Nucleotides; D009712:Nucleotides, Cyclic; D010455:Peptides; D010618:Phenanthrolines; D013501:Surface-Active Agents; D014662:Vasoconstrictor Agents; D012633:Secretin; D001414:Bacitracin; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D000262:Adenylyl Cyclases